Corneal response to Pseudomonas aeruginosa infection

被引:234
|
作者
Hazlett, LD [1 ]
机构
[1] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48201 USA
关键词
P; aeruginosa; cornea; immunity; cells; cytokines; chemokines;
D O I
10.1016/j.preteyeres.2003.10.002
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Pseudomonas aeruginosa (P. aeruginosa) is a common organism associated with bacterial keratitis, especially in those who use extended wear contact lenses. Recent advances in our understanding of host innate and adaptive immune responses to experimental infection have been made using a variety of animal models, including inbred murine models that are classed as resistant (cornea heals) vs. susceptible (cornea perforates). Evidence has been provided that sustained IL-12-driven IFN-gamma production in dominant Th1 responder strains such as C57BL/6 (B6) contributes to corneal destruction and perforation, while IL-18-driven production of IFN-gamma in the absence of IL-12 is associated with bacterial killing and less corneal destruction in dominant Th2 responder strains such as BALB/c. The critical role of IL-1 and chemotactic cytokines such as MIP-2 in PMN recruitment and the critical role of this cell in the innate immune response to bacterial infection is reviewed. Regulation of PMN persistence is also discussed and evidence provided that persistence of PMN in B6 cornea is regulated by CD4(+) T cells, while macrophages regulate PMN number in the cornea of BALB/c mice. The studies provide a better understanding of the inflammatory mechanisms that are operative in the cornea after P. aeruginosa challenge and are consistent with long-term goals of providing targets for alternative or adjunctive treatment for this disease. Future studies will be aimed at better defining the role of Toll receptors, neuropeptides (as unconventional modulators of the immune response) and exploitation of disease control by new techniques, such as RNA silencing. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 30
页数:30
相关论文
共 50 条
  • [41] Role of IL-12 and IFN-γ in Pseudomonas aeruginosa corneal infection
    Hazlett, LD
    Rudner, XL
    McClellan, SA
    Barrett, RP
    Lighvani, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 (02) : 419 - 424
  • [42] Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection
    L D Hazlett
    X Huang
    S A McClellan
    R P Barrett
    Eye, 2003, 17 : 863 - 871
  • [43] Twitching motility contributes to the role of Pili in corneal infection caused by Pseudomonas aeruginosa
    Evans, DJ
    Zolfaghar, I
    To, A
    Fleiszig, SMJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U207 - U207
  • [44] Pseudomonas aeruginosa proteases and corneal virulence
    Hobden, JA
    DNA AND CELL BIOLOGY, 2002, 21 (5-6) : 391 - 396
  • [45] Second harmonic generation imaging of corneal stroma after infection by Pseudomonas aeruginosa
    Robertson, Danielle M.
    Petroll, Matthew
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [46] PSEUDOMONAS-AERUGINOSA INVADES INTO AND SURVIVES INSIDE CELLS DURING CORNEAL INFECTION
    FLEISZIG, SMJ
    ZAIDI, TS
    FLETCHER, EL
    PRESTON, MJ
    PIER, GB
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 901 - 901
  • [47] Primary human corneal fibroblasts release specific matrix metalloproteinases in response to live Pseudomonas aeruginosa infection in-vitro
    Elsahn, Ahmad
    Rodas, Paula
    Christodoulides, Myron
    Hossain, Parwez
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [48] NEUTROPHIL RESPONSE TO PSEUDOMONAS-AERUGINOSA IN RESPIRATORY-INFECTION
    AHMED, K
    DAI, TC
    ICHINOSE, A
    MASAKI, H
    NAGATAKE, T
    MATSUMOTO, K
    MICROBIOLOGY AND IMMUNOLOGY, 1993, 37 (07) : 523 - 529
  • [49] Cellular sources of Interleukin 17 in response to infection with Pseudomonas aeruginosa
    MacPherson, A.
    Evans, T. J.
    IMMUNOLOGY, 2010, 131 : 89 - 89
  • [50] Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection
    Thomsen, Kim
    Hoiby, Niels
    Jensen, Peter Ostrup
    Ciofu, Oana
    Moser, Claus
    BIOMEDICINES, 2022, 10 (09)